Motif ID: Klf4_Sp3
Z-value: 1.215
Transcription factors associated with Klf4_Sp3:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Klf4 | ENSMUSG00000003032.8 | Klf4 |
| Sp3 | ENSMUSG00000027109.10 | Sp3 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Sp3 | mm10_v2_chr2_-_72980402_72980471 | -0.45 | 3.7e-03 | Click! |
| Klf4 | mm10_v2_chr4_-_55532453_55532485 | -0.29 | 7.3e-02 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.2 | 6.7 | GO:0030421 | defecation(GO:0030421) |
| 2.0 | 6.1 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 2.0 | 8.0 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 1.9 | 5.6 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 1.8 | 12.7 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 1.7 | 5.2 | GO:0003360 | brainstem development(GO:0003360) |
| 1.7 | 5.0 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 1.6 | 3.2 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
| 1.6 | 11.1 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
| 1.6 | 7.9 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
| 1.6 | 11.0 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 1.6 | 1.6 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 1.5 | 6.0 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
| 1.5 | 5.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 1.4 | 4.3 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
| 1.4 | 4.3 | GO:0060489 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 1.4 | 7.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 1.4 | 1.4 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
| 1.3 | 4.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
| 1.3 | 4.0 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 1.3 | 3.8 | GO:0036166 | phenotypic switching(GO:0036166) |
| 1.2 | 3.7 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 1.2 | 4.9 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 1.2 | 4.9 | GO:0010288 | response to lead ion(GO:0010288) |
| 1.2 | 1.2 | GO:0090269 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
| 1.2 | 4.9 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 1.2 | 8.4 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 1.2 | 1.2 | GO:0021603 | cranial nerve formation(GO:0021603) |
| 1.2 | 2.3 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 1.1 | 1.1 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 1.1 | 4.6 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 1.1 | 4.6 | GO:1902340 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 1.1 | 3.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 1.1 | 4.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 1.1 | 3.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 1.1 | 11.7 | GO:0003263 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
| 1.1 | 5.3 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 1.1 | 3.2 | GO:0060468 | prevention of polyspermy(GO:0060468) |
| 1.1 | 3.2 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 1.1 | 3.2 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
| 1.1 | 4.2 | GO:0030091 | protein repair(GO:0030091) |
| 1.0 | 1.0 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 1.0 | 5.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 1.0 | 3.0 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 1.0 | 3.9 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 1.0 | 6.9 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 1.0 | 4.9 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 1.0 | 8.7 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 1.0 | 3.9 | GO:0061743 | motor learning(GO:0061743) |
| 1.0 | 2.9 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.9 | 2.8 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.9 | 1.8 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.9 | 2.7 | GO:0070844 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.9 | 7.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.9 | 2.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.9 | 13.2 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.9 | 1.7 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
| 0.9 | 1.7 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 0.9 | 2.6 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
| 0.9 | 3.5 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
| 0.9 | 1.7 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
| 0.9 | 2.6 | GO:2000564 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 0.9 | 2.6 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
| 0.9 | 2.6 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.8 | 0.8 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
| 0.8 | 3.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.8 | 4.1 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
| 0.8 | 3.3 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
| 0.8 | 4.0 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
| 0.8 | 2.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.8 | 5.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.8 | 4.7 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.8 | 6.3 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.8 | 0.8 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.8 | 0.8 | GO:0015744 | succinate transport(GO:0015744) |
| 0.8 | 1.6 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.8 | 5.5 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.8 | 6.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.8 | 3.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.8 | 0.8 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.8 | 3.0 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
| 0.8 | 2.3 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.8 | 6.8 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 0.8 | 8.3 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.7 | 4.5 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.7 | 3.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.7 | 3.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.7 | 3.7 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.7 | 2.2 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.7 | 2.2 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
| 0.7 | 2.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.7 | 5.9 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.7 | 3.7 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.7 | 0.7 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.7 | 2.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.7 | 2.8 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.7 | 2.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.7 | 2.8 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
| 0.7 | 2.8 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.7 | 4.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.7 | 8.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.7 | 4.8 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
| 0.7 | 2.1 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.7 | 10.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 0.7 | 2.7 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.7 | 1.3 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.7 | 1.3 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.7 | 2.0 | GO:0045004 | DNA replication proofreading(GO:0045004) |
| 0.7 | 2.0 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 0.7 | 0.7 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.7 | 2.0 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.7 | 5.9 | GO:0090166 | Golgi disassembly(GO:0090166) |
| 0.7 | 2.0 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.7 | 1.3 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.7 | 2.0 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.6 | 1.3 | GO:0014028 | notochord formation(GO:0014028) |
| 0.6 | 0.6 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.6 | 4.5 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) |
| 0.6 | 1.9 | GO:0016132 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
| 0.6 | 1.9 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.6 | 1.9 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.6 | 2.6 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.6 | 1.3 | GO:0097494 | regulation of vesicle size(GO:0097494) |
| 0.6 | 4.4 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
| 0.6 | 1.9 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.6 | 0.6 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.6 | 7.4 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.6 | 2.5 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
| 0.6 | 2.5 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.6 | 1.9 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.6 | 3.7 | GO:0006105 | succinate metabolic process(GO:0006105) |
| 0.6 | 2.5 | GO:0030576 | Cajal body organization(GO:0030576) |
| 0.6 | 12.9 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.6 | 2.4 | GO:0000050 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
| 0.6 | 0.6 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.6 | 1.8 | GO:0036233 | glycine import(GO:0036233) |
| 0.6 | 1.2 | GO:0046323 | glucose import(GO:0046323) |
| 0.6 | 0.6 | GO:0080144 | amino acid homeostasis(GO:0080144) |
| 0.6 | 1.2 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.6 | 2.4 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.6 | 2.3 | GO:0072236 | metanephric loop of Henle development(GO:0072236) |
| 0.6 | 4.7 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
| 0.6 | 2.3 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
| 0.6 | 0.6 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.6 | 2.3 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
| 0.6 | 1.7 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
| 0.6 | 8.7 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.6 | 1.7 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
| 0.6 | 1.1 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
| 0.6 | 1.1 | GO:0009814 | defense response, incompatible interaction(GO:0009814) |
| 0.6 | 1.7 | GO:0015938 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.6 | 2.3 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.6 | 3.4 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.6 | 5.6 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 0.6 | 0.6 | GO:0032274 | gonadotropin secretion(GO:0032274) |
| 0.6 | 0.6 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.6 | 1.1 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
| 0.6 | 3.3 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.6 | 2.2 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
| 0.6 | 2.2 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
| 0.6 | 1.7 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.5 | 2.7 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
| 0.5 | 0.5 | GO:0018158 | protein oxidation(GO:0018158) |
| 0.5 | 1.6 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.5 | 4.9 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.5 | 1.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.5 | 1.6 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.5 | 4.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.5 | 2.7 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
| 0.5 | 7.0 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.5 | 2.1 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.5 | 1.1 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
| 0.5 | 1.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
| 0.5 | 0.5 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.5 | 1.6 | GO:1905034 | regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
| 0.5 | 6.3 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
| 0.5 | 1.1 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) positive regulation of NAD(P)H oxidase activity(GO:0033864) |
| 0.5 | 4.2 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
| 0.5 | 4.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.5 | 2.1 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.5 | 1.0 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
| 0.5 | 2.1 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.5 | 0.5 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 0.5 | 1.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.5 | 3.1 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.5 | 3.6 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.5 | 1.0 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.5 | 1.0 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.5 | 4.1 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 0.5 | 3.6 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.5 | 2.6 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.5 | 0.5 | GO:0060067 | cervix development(GO:0060067) |
| 0.5 | 1.0 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.5 | 2.6 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.5 | 1.5 | GO:0046061 | dATP catabolic process(GO:0046061) |
| 0.5 | 0.5 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.5 | 2.5 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.5 | 1.5 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.5 | 0.5 | GO:0036482 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
| 0.5 | 1.0 | GO:0021649 | vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve structural organization(GO:0021649) ganglion morphogenesis(GO:0061552) dorsal root ganglion morphogenesis(GO:1904835) |
| 0.5 | 3.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.5 | 3.5 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.5 | 1.0 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
| 0.5 | 2.0 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.5 | 6.6 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.5 | 3.5 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.5 | 4.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.5 | 1.5 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.5 | 2.5 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.5 | 1.5 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.5 | 2.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.5 | 2.0 | GO:0060709 | glycogen cell differentiation involved in embryonic placenta development(GO:0060709) |
| 0.5 | 2.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.5 | 1.4 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
| 0.5 | 1.9 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.5 | 1.4 | GO:0070613 | regulation of protein processing(GO:0070613) |
| 0.5 | 0.5 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
| 0.5 | 1.9 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.5 | 7.6 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
| 0.5 | 1.4 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.5 | 0.9 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.5 | 2.4 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.5 | 7.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.5 | 0.9 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.5 | 0.5 | GO:1900133 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) regulation of renin secretion into blood stream(GO:1900133) |
| 0.5 | 1.4 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
| 0.5 | 1.9 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.5 | 0.9 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
| 0.5 | 2.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.5 | 1.8 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.5 | 2.8 | GO:0021984 | adenohypophysis development(GO:0021984) |
| 0.5 | 1.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.5 | 2.3 | GO:0021978 | telencephalon regionalization(GO:0021978) |
| 0.5 | 5.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.5 | 0.5 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.5 | 1.8 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
| 0.5 | 1.4 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.5 | 2.8 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.5 | 0.9 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
| 0.5 | 1.8 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.5 | 1.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.5 | 0.9 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.5 | 0.9 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
| 0.5 | 0.5 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
| 0.5 | 1.4 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.5 | 5.4 | GO:0000052 | citrulline metabolic process(GO:0000052) |
| 0.5 | 0.9 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
| 0.5 | 1.4 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.4 | 1.8 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
| 0.4 | 2.2 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
| 0.4 | 1.3 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.4 | 3.1 | GO:0060579 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
| 0.4 | 1.8 | GO:0032532 | regulation of microvillus length(GO:0032532) |
| 0.4 | 2.2 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.4 | 1.3 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.4 | 2.7 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.4 | 0.9 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
| 0.4 | 0.9 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.4 | 2.6 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
| 0.4 | 0.9 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.4 | 11.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.4 | 1.3 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.4 | 2.6 | GO:0003383 | apical constriction(GO:0003383) |
| 0.4 | 2.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.4 | 1.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.4 | 5.6 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.4 | 1.7 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.4 | 0.9 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.4 | 0.4 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 0.4 | 1.3 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.4 | 2.1 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.4 | 1.3 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.4 | 1.7 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.4 | 1.3 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.4 | 7.6 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
| 0.4 | 3.8 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.4 | 3.4 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.4 | 4.6 | GO:0060539 | diaphragm development(GO:0060539) |
| 0.4 | 0.8 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.4 | 3.8 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.4 | 0.8 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
| 0.4 | 0.4 | GO:0001946 | lymphangiogenesis(GO:0001946) |
| 0.4 | 0.4 | GO:0071451 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
| 0.4 | 0.8 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.4 | 0.4 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.4 | 0.4 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
| 0.4 | 1.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.4 | 2.5 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.4 | 2.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.4 | 1.2 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.4 | 2.1 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 0.4 | 3.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.4 | 1.6 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 0.4 | 0.8 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.4 | 1.2 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.4 | 4.9 | GO:0048368 | lateral mesoderm development(GO:0048368) |
| 0.4 | 1.6 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.4 | 5.3 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.4 | 0.4 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
| 0.4 | 0.4 | GO:0060037 | pharyngeal system development(GO:0060037) |
| 0.4 | 1.6 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
| 0.4 | 1.2 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.4 | 0.8 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.4 | 3.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.4 | 0.4 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.4 | 3.6 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.4 | 2.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.4 | 1.2 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.4 | 1.6 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.4 | 0.4 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
| 0.4 | 1.2 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
| 0.4 | 0.8 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.4 | 0.4 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.4 | 1.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
| 0.4 | 5.9 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.4 | 0.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.4 | 2.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.4 | 3.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.4 | 1.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.4 | 1.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.4 | 1.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
| 0.4 | 0.4 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 0.4 | 1.9 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.4 | 2.7 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
| 0.4 | 1.5 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.4 | 2.7 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.4 | 0.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.4 | 3.5 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.4 | 1.9 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.4 | 1.5 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 0.4 | 0.8 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.4 | 0.8 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
| 0.4 | 1.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.4 | 9.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.4 | 1.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.4 | 1.5 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.4 | 1.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.4 | 1.9 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.4 | 1.5 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
| 0.4 | 3.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.4 | 0.4 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.4 | 2.2 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.4 | 0.4 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.4 | 1.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.4 | 0.7 | GO:0090298 | negative regulation of mitochondrial DNA replication(GO:0090298) |
| 0.4 | 0.7 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.4 | 1.1 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 0.4 | 0.7 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.4 | 2.2 | GO:0036089 | cleavage furrow formation(GO:0036089) |
| 0.4 | 2.9 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.4 | 3.2 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.4 | 1.1 | GO:0032369 | negative regulation of lipid transport(GO:0032369) |
| 0.4 | 1.4 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.4 | 1.4 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.4 | 2.1 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.4 | 5.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.4 | 0.4 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
| 0.4 | 1.1 | GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
| 0.3 | 5.9 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.3 | 0.7 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.3 | 0.3 | GO:1900150 | regulation of defense response to fungus(GO:1900150) |
| 0.3 | 0.3 | GO:0097242 | beta-amyloid clearance(GO:0097242) regulation of beta-amyloid clearance(GO:1900221) |
| 0.3 | 1.0 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
| 0.3 | 2.4 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.3 | 0.3 | GO:0070672 | response to interleukin-15(GO:0070672) |
| 0.3 | 0.3 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.3 | 0.7 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.3 | 1.4 | GO:1903416 | response to glycoside(GO:1903416) |
| 0.3 | 1.4 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.3 | 0.7 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
| 0.3 | 1.0 | GO:0034035 | sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.3 | 1.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.3 | 1.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.3 | 0.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.3 | 3.7 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
| 0.3 | 0.7 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
| 0.3 | 1.3 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.3 | 0.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.3 | 1.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.3 | 4.6 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
| 0.3 | 0.7 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.3 | 1.0 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.3 | 1.3 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
| 0.3 | 0.3 | GO:0090189 | positive regulation of mesonephros development(GO:0061213) regulation of branching involved in ureteric bud morphogenesis(GO:0090189) |
| 0.3 | 0.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.3 | 2.9 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.3 | 1.3 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
| 0.3 | 0.6 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.3 | 3.2 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.3 | 1.0 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.3 | 0.6 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.3 | 0.3 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.3 | 6.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.3 | 1.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.3 | 9.0 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.3 | 1.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.3 | 1.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 0.3 | 1.0 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.3 | 1.6 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.3 | 0.6 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.3 | 1.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 0.3 | 0.6 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.3 | 2.8 | GO:0051195 | negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.3 | 5.3 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.3 | 1.6 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.3 | 1.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.3 | 1.6 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.3 | 1.2 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.3 | 0.6 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.3 | 3.4 | GO:0021924 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 0.3 | 1.5 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.3 | 2.4 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.3 | 0.3 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
| 0.3 | 1.5 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.3 | 0.6 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
| 0.3 | 0.9 | GO:0001907 | killing by symbiont of host cells(GO:0001907) induction of programmed cell death(GO:0012502) disruption by symbiont of host cell(GO:0044004) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
| 0.3 | 2.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 0.3 | 1.5 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.3 | 1.8 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.3 | 0.3 | GO:0048625 | myoblast fate commitment(GO:0048625) |
| 0.3 | 0.9 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
| 0.3 | 0.6 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.3 | 2.1 | GO:0015675 | nickel cation transport(GO:0015675) |
| 0.3 | 0.3 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.3 | 0.6 | GO:0032493 | response to bacterial lipoprotein(GO:0032493) |
| 0.3 | 0.6 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
| 0.3 | 0.3 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.3 | 0.9 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
| 0.3 | 2.6 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.3 | 2.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.3 | 1.7 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.3 | 1.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.3 | 1.2 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
| 0.3 | 4.3 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
| 0.3 | 0.3 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.3 | 0.3 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.3 | 1.4 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.3 | 1.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.3 | 1.1 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.3 | 0.6 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
| 0.3 | 1.1 | GO:0046036 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
| 0.3 | 1.1 | GO:1904451 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
| 0.3 | 0.3 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.3 | 2.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.3 | 0.3 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
| 0.3 | 1.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
| 0.3 | 0.3 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) |
| 0.3 | 0.3 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
| 0.3 | 3.8 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
| 0.3 | 0.8 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.3 | 2.5 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.3 | 0.3 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.3 | 1.9 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.3 | 0.3 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.3 | 0.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.3 | 2.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.3 | 1.6 | GO:0015791 | polyol transport(GO:0015791) |
| 0.3 | 1.1 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.3 | 2.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.3 | 0.5 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
| 0.3 | 7.4 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.3 | 2.1 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.3 | 2.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.3 | 6.9 | GO:0034508 | centromere complex assembly(GO:0034508) |
| 0.3 | 1.0 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.3 | 0.3 | GO:0061511 | centriole elongation(GO:0061511) |
| 0.3 | 0.5 | GO:0014891 | striated muscle atrophy(GO:0014891) |
| 0.3 | 0.5 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
| 0.3 | 1.3 | GO:0033504 | floor plate development(GO:0033504) |
| 0.3 | 0.5 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.3 | 4.4 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.3 | 0.8 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.3 | 0.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.3 | 2.3 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.3 | 0.5 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
| 0.3 | 2.8 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.3 | 0.8 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.3 | 0.8 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.3 | 1.3 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
| 0.3 | 0.8 | GO:0001193 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.3 | 0.8 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.3 | 1.5 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
| 0.3 | 1.5 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
| 0.3 | 0.3 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
| 0.2 | 1.7 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.2 | 0.5 | GO:0009437 | carnitine metabolic process(GO:0009437) |
| 0.2 | 0.7 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.2 | 0.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.2 | 0.7 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 | 1.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 0.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.2 | 2.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.2 | 0.5 | GO:2000851 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.2 | 0.7 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 0.2 | 1.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.2 | 1.5 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 0.2 | 0.2 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.2 | 1.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.2 | 1.7 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.2 | 0.7 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.2 | 12.3 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.2 | 1.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.2 | 0.7 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.2 | 0.5 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.2 | 1.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.2 | 1.9 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.2 | 1.4 | GO:1902592 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
| 0.2 | 1.4 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.2 | 0.2 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.2 | 1.2 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
| 0.2 | 0.7 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.2 | 0.7 | GO:0019405 | alditol catabolic process(GO:0019405) |
| 0.2 | 1.4 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.2 | 8.3 | GO:0006284 | base-excision repair(GO:0006284) |
| 0.2 | 0.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.2 | 0.9 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.2 | 2.8 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.2 | 2.8 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.2 | 1.9 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.2 | 0.2 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 0.2 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.2 | 2.8 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
| 0.2 | 0.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 0.2 | 0.5 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 0.2 | 0.7 | GO:0009414 | response to water deprivation(GO:0009414) |
| 0.2 | 1.1 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
| 0.2 | 1.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.2 | 0.2 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 0.2 | 4.6 | GO:0035036 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.2 | 0.5 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.2 | 0.2 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.2 | 0.7 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.2 | 0.2 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.2 | 0.9 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.2 | 1.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.2 | 0.7 | GO:0072070 | loop of Henle development(GO:0072070) specification of loop of Henle identity(GO:0072086) |
| 0.2 | 1.8 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 0.2 | 0.2 | GO:1902946 | protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.2 | 1.6 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.2 | 0.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.2 | 2.0 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
| 0.2 | 1.3 | GO:0032196 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) transposition(GO:0032196) |
| 0.2 | 6.9 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.2 | 0.4 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.2 | 1.1 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.2 | 0.7 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.2 | 2.4 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.2 | 0.9 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.2 | 2.4 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
| 0.2 | 0.2 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.2 | 0.7 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
| 0.2 | 0.4 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
| 0.2 | 0.7 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.2 | 0.4 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.2 | 3.0 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.2 | 0.2 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.2 | 0.6 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.2 | 3.6 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.2 | 0.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
| 0.2 | 0.4 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
| 0.2 | 0.8 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.2 | 0.2 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
| 0.2 | 0.2 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.2 | 0.4 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 0.2 | 0.6 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.2 | 1.0 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.2 | 0.4 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
| 0.2 | 1.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.2 | 1.5 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.2 | 0.4 | GO:0032816 | positive regulation of natural killer cell activation(GO:0032816) |
| 0.2 | 0.6 | GO:1901675 | response to methylglyoxal(GO:0051595) negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.2 | 1.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.2 | 0.8 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.2 | 4.1 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.2 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.2 | 0.6 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.2 | 2.3 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.2 | 0.4 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.2 | 0.6 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.2 | 0.4 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
| 0.2 | 0.4 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
| 0.2 | 0.4 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
| 0.2 | 3.0 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.2 | 0.6 | GO:0030222 | eosinophil differentiation(GO:0030222) |
| 0.2 | 0.8 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.2 | 0.2 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
| 0.2 | 0.4 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.2 | 0.4 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.2 | 0.8 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.2 | 1.6 | GO:0050892 | intestinal absorption(GO:0050892) |
| 0.2 | 2.2 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) |
| 0.2 | 0.2 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
| 0.2 | 1.2 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.2 | 0.8 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.2 | 1.4 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.2 | 2.2 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
| 0.2 | 0.6 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
| 0.2 | 0.8 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.2 | 8.0 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.2 | 1.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.2 | 0.4 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.2 | 2.5 | GO:0048535 | lymph node development(GO:0048535) |
| 0.2 | 1.1 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.2 | 1.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.2 | 4.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.2 | 0.6 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.2 | 3.8 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
| 0.2 | 1.0 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.2 | 1.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.2 | 1.1 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
| 0.2 | 0.4 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.2 | 0.6 | GO:0061038 | uterus morphogenesis(GO:0061038) |
| 0.2 | 1.7 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.2 | 0.2 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
| 0.2 | 0.6 | GO:0009106 | lipoate metabolic process(GO:0009106) |
| 0.2 | 0.2 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
| 0.2 | 0.4 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.2 | 0.2 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.2 | 0.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.2 | 1.3 | GO:0048546 | digestive tract morphogenesis(GO:0048546) |
| 0.2 | 0.2 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.2 | 1.3 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.2 | 0.2 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 0.2 | 0.6 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
| 0.2 | 4.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.2 | 1.5 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.2 | 0.7 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
| 0.2 | 1.7 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.2 | 2.7 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.2 | 0.2 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
| 0.2 | 0.7 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
| 0.2 | 0.7 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.2 | 0.4 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.2 | 0.4 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.2 | 0.4 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
| 0.2 | 0.7 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.2 | 0.4 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.2 | 0.7 | GO:1903028 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
| 0.2 | 0.4 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.2 | 0.5 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
| 0.2 | 0.7 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.2 | 0.7 | GO:0032053 | ciliary basal body organization(GO:0032053) |
| 0.2 | 2.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 | 0.4 | GO:1903273 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
| 0.2 | 6.2 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
| 0.2 | 0.7 | GO:0030578 | PML body organization(GO:0030578) |
| 0.2 | 0.2 | GO:0071863 | regulation of cell proliferation in bone marrow(GO:0071863) |
| 0.2 | 0.4 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
| 0.2 | 1.1 | GO:0021539 | subthalamus development(GO:0021539) |
| 0.2 | 1.1 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.2 | 0.7 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 0.2 | 0.3 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 0.2 | 4.9 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.2 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
| 0.2 | 4.2 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.2 | 0.2 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.2 | 0.7 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.2 | 0.2 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.2 | 1.9 | GO:1901991 | negative regulation of mitotic cell cycle phase transition(GO:1901991) |
| 0.2 | 1.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 0.2 | 0.3 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
| 0.2 | 0.7 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.2 | 1.0 | GO:0051461 | regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.2 | 0.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
| 0.2 | 0.3 | GO:0031047 | gene silencing by RNA(GO:0031047) |
| 0.2 | 0.5 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.2 | 1.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.2 | 0.5 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.2 | 2.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.2 | 2.2 | GO:0042407 | cristae formation(GO:0042407) |
| 0.2 | 0.2 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
| 0.2 | 1.2 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) negative regulation of cell cycle G2/M phase transition(GO:1902750) |
| 0.2 | 1.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.2 | 4.0 | GO:0007566 | embryo implantation(GO:0007566) |
| 0.2 | 0.2 | GO:0006573 | valine metabolic process(GO:0006573) |
| 0.2 | 0.3 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.2 | 1.7 | GO:0034244 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.2 | 0.3 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.2 | 4.8 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
| 0.2 | 1.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.2 | 1.0 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.2 | 0.2 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.2 | 2.0 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
| 0.2 | 0.8 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.2 | 0.6 | GO:0044241 | lipid digestion(GO:0044241) |
| 0.2 | 0.3 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
| 0.2 | 1.1 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 0.2 | 0.6 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.2 | 0.8 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.2 | 0.3 | GO:0060677 | ureteric bud elongation(GO:0060677) |
| 0.2 | 0.3 | GO:0099550 | trans-synaptic signalling, modulating synaptic transmission(GO:0099550) |
| 0.2 | 0.8 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
| 0.2 | 0.3 | GO:0001765 | membrane raft assembly(GO:0001765) |
| 0.2 | 0.3 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 0.2 | 1.4 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
| 0.2 | 0.5 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
| 0.2 | 0.8 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.2 | 0.2 | GO:1904426 | positive regulation of GTP binding(GO:1904426) |
| 0.2 | 0.6 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.2 | 1.4 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.2 | 0.3 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
| 0.2 | 0.8 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.2 | 0.3 | GO:0060426 | lung vasculature development(GO:0060426) |
| 0.2 | 1.3 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.2 | 0.2 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.2 | 0.8 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
| 0.2 | 0.6 | GO:0030220 | platelet formation(GO:0030220) |
| 0.2 | 0.6 | GO:0015786 | UDP-glucose transport(GO:0015786) protein O-linked fucosylation(GO:0036066) |
| 0.2 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
| 0.2 | 1.2 | GO:0018126 | protein hydroxylation(GO:0018126) |
| 0.2 | 2.0 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.2 | 0.6 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.2 | 0.8 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.2 | 0.6 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.2 | 0.9 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
| 0.2 | 1.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.2 | 0.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.2 | 0.3 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.2 | 1.4 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.2 | 0.8 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
| 0.1 | 0.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.1 | 0.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 | 0.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.1 | 0.7 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.1 | 0.4 | GO:0042448 | progesterone metabolic process(GO:0042448) |
| 0.1 | 0.3 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
| 0.1 | 1.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.1 | 2.1 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.1 | 0.1 | GO:0002385 | mucosal immune response(GO:0002385) |
| 0.1 | 0.4 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.1 | 3.7 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.1 | 0.9 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 0.1 | 1.0 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.1 | 0.4 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
| 0.1 | 0.1 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
| 0.1 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.1 | 0.3 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.1 | 0.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
| 0.1 | 0.4 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
| 0.1 | 0.1 | GO:0060214 | stem cell fate commitment(GO:0048865) stem cell fate specification(GO:0048866) endocardium formation(GO:0060214) |
| 0.1 | 0.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.1 | 0.1 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
| 0.1 | 1.8 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
| 0.1 | 0.7 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.1 | 0.1 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
| 0.1 | 0.7 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.1 | 0.4 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.1 | 0.4 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.1 | 0.4 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
| 0.1 | 0.1 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.1 | 3.2 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 | 1.0 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.1 | 0.3 | GO:0060393 | regulation of pathway-restricted SMAD protein phosphorylation(GO:0060393) |
| 0.1 | 0.3 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.1 | 0.8 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.1 | 0.4 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
| 0.1 | 0.6 | GO:0042730 | fibrinolysis(GO:0042730) |
| 0.1 | 0.7 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.1 | 0.3 | GO:0000305 | response to oxygen radical(GO:0000305) |
| 0.1 | 0.1 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 0.1 | 0.1 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.1 | 0.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
| 0.1 | 0.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.1 | 0.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
| 0.1 | 0.1 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
| 0.1 | 0.4 | GO:0010155 | regulation of proton transport(GO:0010155) |
| 0.1 | 0.7 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.1 | 1.1 | GO:0060736 | prostate gland growth(GO:0060736) |
| 0.1 | 1.9 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.1 | 0.3 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
| 0.1 | 0.3 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.1 | 0.9 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.1 | 0.1 | GO:0006404 | RNA import into nucleus(GO:0006404) |
| 0.1 | 0.5 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
| 0.1 | 0.4 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.1 | 0.3 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
| 0.1 | 0.3 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
| 0.1 | 1.3 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) |
| 0.1 | 4.8 | GO:0009060 | aerobic respiration(GO:0009060) |
| 0.1 | 1.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 | 1.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.1 | 0.3 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
| 0.1 | 1.2 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.1 | 0.6 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 | 0.1 | GO:0002432 | granuloma formation(GO:0002432) |
| 0.1 | 0.9 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 | 0.4 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.1 | 0.9 | GO:0010574 | regulation of vascular endothelial growth factor production(GO:0010574) |
| 0.1 | 1.7 | GO:0006000 | fructose metabolic process(GO:0006000) |
| 0.1 | 0.6 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
| 0.1 | 0.6 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.1 | 1.7 | GO:0007530 | sex determination(GO:0007530) |
| 0.1 | 0.6 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.1 | 0.3 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 | 5.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.1 | 0.4 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.1 | 0.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 | 0.6 | GO:0071168 | protein localization to chromatin(GO:0071168) |
| 0.1 | 0.4 | GO:0030432 | peristalsis(GO:0030432) |
| 0.1 | 0.3 | GO:0099625 | ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
| 0.1 | 0.6 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
| 0.1 | 0.4 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.1 | 0.9 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
| 0.1 | 1.4 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.1 | 0.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 | 0.9 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.1 | 1.1 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
| 0.1 | 2.2 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.1 | 2.6 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
| 0.1 | 0.1 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.1 | 4.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
| 0.1 | 0.4 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.1 | 1.3 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.1 | 1.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 | 0.1 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.1 | 1.2 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.1 | 0.5 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 | 2.0 | GO:0033865 | coenzyme A metabolic process(GO:0015936) nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
| 0.1 | 0.4 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.1 | 0.1 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.1 | 0.2 | GO:1904353 | regulation of telomere capping(GO:1904353) |
| 0.1 | 0.2 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.1 | 0.4 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.1 | 0.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 | 0.2 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
| 0.1 | 0.2 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
| 0.1 | 0.3 | GO:0048209 | regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
| 0.1 | 0.1 | GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus(GO:0002866) |
| 0.1 | 0.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
| 0.1 | 0.2 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.1 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.1 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.1 | 0.5 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 0.1 | 0.5 | GO:0015705 | iodide transport(GO:0015705) |
| 0.1 | 0.2 | GO:0060676 | ureteric bud formation(GO:0060676) |
| 0.1 | 0.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.1 | 0.6 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.1 | 0.5 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.1 | 0.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.1 | 1.6 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.1 | 0.1 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.1 | 1.9 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.1 | 0.9 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.1 | 1.6 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.1 | 5.1 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
| 0.1 | 1.0 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.1 | 0.5 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.1 | 1.4 | GO:2000780 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
| 0.1 | 0.3 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 | 2.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.1 | 0.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.1 | 1.2 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 | 0.6 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.1 | 0.1 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
| 0.1 | 0.2 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.1 | 0.2 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
| 0.1 | 1.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 | 1.7 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
| 0.1 | 0.1 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.1 | 1.0 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.1 | 0.1 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
| 0.1 | 0.3 | GO:0072376 | protein activation cascade(GO:0072376) |
| 0.1 | 0.7 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.1 | 4.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.1 | 0.4 | GO:0016137 | glycoside metabolic process(GO:0016137) |
| 0.1 | 0.3 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
| 0.1 | 1.0 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 | 0.1 | GO:0044788 | modulation by host of viral process(GO:0044788) modulation by host of viral genome replication(GO:0044827) |
| 0.1 | 0.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 | 0.7 | GO:0006551 | leucine metabolic process(GO:0006551) |
| 0.1 | 0.1 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.1 | 0.2 | GO:0008209 | androgen metabolic process(GO:0008209) |
| 0.1 | 0.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 | 0.6 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 | 1.7 | GO:0006959 | humoral immune response(GO:0006959) |
| 0.1 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 | 0.7 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
| 0.1 | 0.9 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
| 0.1 | 0.3 | GO:0046548 | retinal rod cell development(GO:0046548) |
| 0.1 | 0.4 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.1 | 0.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 | 0.9 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.1 | 0.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 0.1 | 0.7 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.1 | 0.2 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.1 | 0.5 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.1 | 0.1 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.1 | 0.2 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.1 | 0.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.1 | 0.5 | GO:0060347 | heart trabecula formation(GO:0060347) |
| 0.1 | 2.0 | GO:0035411 | catenin import into nucleus(GO:0035411) |
| 0.1 | 0.3 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
| 0.1 | 0.3 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.1 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 | 0.5 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.1 | 0.4 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.1 | 0.6 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
| 0.1 | 0.2 | GO:0045978 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
| 0.1 | 2.7 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.1 | 0.6 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 | 0.5 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
| 0.1 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
| 0.1 | 0.5 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
| 0.1 | 0.2 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.1 | 0.5 | GO:0030224 | monocyte differentiation(GO:0030224) |
| 0.1 | 0.5 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.1 | 0.2 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
| 0.1 | 0.5 | GO:0032329 | serine transport(GO:0032329) |
| 0.1 | 0.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 | 0.9 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
| 0.1 | 0.1 | GO:1904809 | dense core granule localization(GO:0032253) dense core granule transport(GO:1901950) regulation of dense core granule transport(GO:1904809) positive regulation of dense core granule transport(GO:1904811) |
| 0.1 | 0.1 | GO:0061525 | hindgut development(GO:0061525) |
| 0.1 | 0.6 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
| 0.1 | 0.8 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
| 0.1 | 0.3 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
| 0.1 | 0.5 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.1 | 0.2 | GO:0010934 | macrophage cytokine production(GO:0010934) |
| 0.1 | 1.4 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
| 0.1 | 0.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 | 0.4 | GO:0035994 | response to muscle stretch(GO:0035994) |
| 0.1 | 0.5 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
| 0.1 | 0.5 | GO:0007588 | excretion(GO:0007588) |
| 0.1 | 0.8 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
| 0.1 | 0.5 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
| 0.1 | 0.3 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.1 | 1.3 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
| 0.1 | 0.3 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
| 0.1 | 1.0 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
| 0.1 | 0.5 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
| 0.1 | 0.3 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 0.1 | 0.8 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 0.1 | 0.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 | 0.3 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.1 | 0.4 | GO:0032796 | uropod organization(GO:0032796) |
| 0.1 | 0.2 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
| 0.1 | 0.2 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.1 | 0.3 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
| 0.1 | 0.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 0.1 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 0.1 | 0.2 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 | 0.2 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
| 0.1 | 3.0 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.1 | 0.3 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
| 0.1 | 0.1 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
| 0.1 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 | 0.2 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
| 0.1 | 2.3 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.1 | 0.7 | GO:0036296 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) |
| 0.1 | 1.5 | GO:0030279 | negative regulation of ossification(GO:0030279) |
| 0.1 | 0.4 | GO:0015817 | histidine transport(GO:0015817) |
| 0.1 | 0.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 0.1 | 0.6 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
| 0.1 | 0.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
| 0.1 | 1.4 | GO:0007614 | short-term memory(GO:0007614) |
| 0.1 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.1 | 1.5 | GO:0060325 | face morphogenesis(GO:0060325) |
| 0.1 | 0.6 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.1 | 0.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.1 | 0.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.1 | 0.2 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.1 | 1.9 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 | 0.3 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.1 | 0.2 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 0.1 | 0.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.1 | 0.5 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
| 0.1 | 0.2 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.1 | 0.4 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
| 0.1 | 0.4 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.1 | 0.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.1 | 0.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.1 | 0.4 | GO:0042447 | hormone catabolic process(GO:0042447) |
| 0.1 | 0.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.1 | 0.4 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.1 | 0.4 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
| 0.1 | 0.4 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
| 0.1 | 0.4 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.1 | 0.6 | GO:0014823 | response to activity(GO:0014823) |
| 0.1 | 0.1 | GO:0035878 | nail development(GO:0035878) |
| 0.1 | 0.4 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
| 0.1 | 0.1 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
| 0.1 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.1 | 0.1 | GO:0043276 | anoikis(GO:0043276) |
| 0.1 | 0.5 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.1 | 0.1 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
| 0.1 | 0.8 | GO:0010586 | miRNA metabolic process(GO:0010586) |
| 0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.1 | 0.1 | GO:0048793 | pronephros development(GO:0048793) |
| 0.1 | 0.2 | GO:0046851 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
| 0.1 | 0.4 | GO:0042168 | heme metabolic process(GO:0042168) |
| 0.1 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 | 0.4 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
| 0.1 | 0.4 | GO:0070670 | response to interleukin-4(GO:0070670) |
| 0.1 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.1 | 1.9 | GO:0032526 | response to retinoic acid(GO:0032526) |
| 0.1 | 0.9 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.1 | 0.3 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
| 0.1 | 0.2 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
| 0.1 | 0.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.1 | 0.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.1 | 0.2 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
| 0.1 | 3.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
| 0.1 | 1.0 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.1 | 0.1 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
| 0.1 | 0.2 | GO:0002467 | germinal center formation(GO:0002467) |
| 0.1 | 0.1 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 0.1 | 0.1 | GO:0014016 | neuroblast differentiation(GO:0014016) |
| 0.1 | 0.1 | GO:0060244 | contact inhibition(GO:0060242) negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.1 | 0.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.1 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.1 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.1 | 0.1 | GO:0050703 | interleukin-1 alpha production(GO:0032610) interleukin-1 alpha secretion(GO:0050703) |
| 0.1 | 0.5 | GO:0030049 | muscle filament sliding(GO:0030049) |
| 0.1 | 0.1 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
| 0.1 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
| 0.1 | 0.4 | GO:0015074 | DNA integration(GO:0015074) |
| 0.1 | 0.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 | 0.2 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.1 | 0.2 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.1 | 0.4 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
| 0.1 | 0.2 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
| 0.1 | 0.1 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
| 0.1 | 1.2 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.1 | 0.3 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.1 | 0.3 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.1 | 0.1 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.1 | 0.3 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.1 | 0.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.1 | 0.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.1 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.1 | 0.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.1 | 0.4 | GO:0030728 | ovulation(GO:0030728) |
| 0.1 | 0.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 | 0.2 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 | 0.2 | GO:0030903 | notochord development(GO:0030903) |
| 0.1 | 0.2 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.1 | 0.2 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
| 0.1 | 0.2 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
| 0.1 | 0.2 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.1 | 0.2 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
| 0.1 | 0.8 | GO:0051180 | vitamin transport(GO:0051180) |
| 0.1 | 0.2 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
| 0.1 | 0.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.1 | 0.4 | GO:0030575 | nuclear body organization(GO:0030575) |
| 0.0 | 0.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.0 | 0.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.0 | 1.4 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
| 0.0 | 1.5 | GO:0006414 | translational elongation(GO:0006414) |
| 0.0 | 0.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 | 0.5 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.0 | 0.2 | GO:0060033 | anatomical structure regression(GO:0060033) |
| 0.0 | 0.2 | GO:0032310 | prostaglandin secretion(GO:0032310) |
| 0.0 | 0.4 | GO:0033692 | cellular polysaccharide biosynthetic process(GO:0033692) |
| 0.0 | 0.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.0 | 0.9 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
| 0.0 | 0.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.0 | 0.9 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.0 | 0.2 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
| 0.0 | 0.1 | GO:0000279 | M phase(GO:0000279) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
| 0.0 | 0.0 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 0.0 | 0.1 | GO:0050779 | RNA destabilization(GO:0050779) |
| 0.0 | 0.2 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.0 | 0.4 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
| 0.0 | 0.2 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
| 0.0 | 0.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.0 | 0.3 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
| 0.0 | 0.1 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
| 0.0 | 0.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.0 | 0.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.0 | 0.1 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
| 0.0 | 0.0 | GO:0060174 | limb bud formation(GO:0060174) |
| 0.0 | 0.2 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.0 | 1.2 | GO:0070206 | protein trimerization(GO:0070206) |
| 0.0 | 0.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.0 | 0.2 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 0.0 | 0.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.0 | 0.1 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.0 | 0.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 | 0.2 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 | 0.1 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
| 0.0 | 0.0 | GO:0019883 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous antigen(GO:0019883) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.0 | 0.2 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.0 | 0.2 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.0 | 0.5 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
| 0.0 | 0.4 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
| 0.0 | 0.2 | GO:0034698 | response to gonadotropin(GO:0034698) cellular response to gonadotropin stimulus(GO:0071371) |
| 0.0 | 0.1 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
| 0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
| 0.0 | 0.4 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.0 | 0.9 | GO:0060425 | lung morphogenesis(GO:0060425) |
| 0.0 | 0.1 | GO:0015840 | urea transport(GO:0015840) urea transmembrane transport(GO:0071918) |
| 0.0 | 0.4 | GO:0046849 | bone remodeling(GO:0046849) |
| 0.0 | 0.3 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) |
| 0.0 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 0.0 | 0.1 | GO:0042832 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
| 0.0 | 0.0 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.0 | 0.2 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
| 0.0 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
| 0.0 | 0.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.0 | 0.1 | GO:0006507 | GPI anchor release(GO:0006507) |
| 0.0 | 0.9 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.0 | 0.1 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
| 0.0 | 0.1 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 | 0.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 | 0.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.0 | 0.5 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
| 0.0 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.0 | 0.1 | GO:0006405 | RNA export from nucleus(GO:0006405) |
| 0.0 | 0.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 | 0.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.0 | 0.2 | GO:0046364 | hexose biosynthetic process(GO:0019319) monosaccharide biosynthetic process(GO:0046364) |
| 0.0 | 0.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.0 | 0.6 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.0 | 0.2 | GO:0021511 | spinal cord patterning(GO:0021511) |
| 0.0 | 0.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.0 | 0.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 | 0.3 | GO:0019321 | pentose metabolic process(GO:0019321) |
| 0.0 | 0.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 | 0.6 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.0 | 0.4 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
| 0.0 | 0.2 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
| 0.0 | 0.0 | GO:0032365 | intracellular lipid transport(GO:0032365) |
| 0.0 | 0.3 | GO:0019835 | cytolysis(GO:0019835) |
| 0.0 | 0.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
| 0.0 | 0.1 | GO:0016246 | RNA interference(GO:0016246) |
| 0.0 | 0.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.0 | 0.1 | GO:0034773 | histone H4-K20 methylation(GO:0034770) histone H4-K20 trimethylation(GO:0034773) |
| 0.0 | 0.1 | GO:0031295 | T cell costimulation(GO:0031295) |
| 0.0 | 1.0 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.0 | 0.2 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
| 0.0 | 0.1 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
| 0.0 | 0.3 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
| 0.0 | 0.2 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
| 0.0 | 0.2 | GO:0045445 | myoblast differentiation(GO:0045445) |
| 0.0 | 0.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
| 0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.0 | 0.2 | GO:2000816 | negative regulation of mitotic sister chromatid separation(GO:2000816) |
| 0.0 | 0.0 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 0.0 | 0.7 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.0 | 0.2 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
| 0.0 | 0.1 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.0 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
| 0.0 | 0.1 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.0 | 0.2 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
| 0.0 | 0.0 | GO:0006848 | pyruvate transport(GO:0006848) |
| 0.0 | 0.0 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.0 | 0.2 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.0 | 0.2 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 | 0.3 | GO:0031529 | ruffle organization(GO:0031529) |
| 0.0 | 0.3 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
| 0.0 | 1.5 | GO:0045137 | development of primary sexual characteristics(GO:0045137) |
| 0.0 | 0.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.0 | 0.0 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 0.0 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.0 | 0.6 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
| 0.0 | 0.5 | GO:0071229 | cellular response to acid chemical(GO:0071229) |
| 0.0 | 0.1 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.0 | 0.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
| 0.0 | 0.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.0 | 0.1 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.0 | 0.1 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
| 0.0 | 0.3 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
| 0.0 | 0.0 | GO:0032355 | response to estradiol(GO:0032355) |
| 0.0 | 0.2 | GO:0006825 | copper ion transport(GO:0006825) |
| 0.0 | 0.1 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
| 0.0 | 0.1 | GO:0002190 | cap-independent translational initiation(GO:0002190) |
| 0.0 | 0.2 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
| 0.0 | 0.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.0 | 0.0 | GO:0033239 | regulation of glutamine family amino acid metabolic process(GO:0000820) negative regulation of cellular amine metabolic process(GO:0033239) regulation of glutamate metabolic process(GO:2000211) |
| 0.0 | 0.1 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
| 0.0 | 0.2 | GO:0099628 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
| 0.0 | 0.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
| 0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.0 | 0.1 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
| 0.0 | 0.1 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
| 0.0 | 0.1 | GO:0009169 | nucleoside monophosphate catabolic process(GO:0009125) purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
| 0.0 | 0.0 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.0 | 0.1 | GO:0009201 | ribonucleoside triphosphate biosynthetic process(GO:0009201) |
| 0.0 | 0.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.0 | 0.1 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.0 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.0 | 0.0 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
| 0.0 | 0.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 0.0 | 0.4 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.0 | 0.0 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.0 | 0.1 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
| 0.0 | 0.2 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
| 0.0 | 0.0 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.0 | 0.1 | GO:0051782 | negative regulation of cell division(GO:0051782) |
| 0.0 | 0.0 | GO:0070723 | response to sterol(GO:0036314) response to cholesterol(GO:0070723) |
| 0.0 | 0.0 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
| 0.0 | 0.0 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
| 0.0 | 0.0 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.8 | 7.2 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 1.7 | 5.2 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 1.6 | 4.8 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 1.5 | 6.0 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
| 1.5 | 5.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
| 1.5 | 7.3 | GO:1990246 | uniplex complex(GO:1990246) |
| 1.4 | 6.8 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 1.2 | 10.0 | GO:0016600 | flotillin complex(GO:0016600) |
| 1.2 | 5.9 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 1.2 | 3.5 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
| 1.0 | 4.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 1.0 | 6.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.9 | 8.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.8 | 0.8 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
| 0.8 | 5.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.8 | 2.3 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.8 | 2.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.8 | 7.5 | GO:0000805 | X chromosome(GO:0000805) |
| 0.7 | 4.5 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 0.7 | 2.2 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 0.7 | 4.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.7 | 1.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.7 | 3.5 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
| 0.7 | 2.1 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.7 | 6.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.6 | 4.5 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.6 | 1.9 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
| 0.6 | 2.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.6 | 3.0 | GO:0044301 | climbing fiber(GO:0044301) |
| 0.6 | 3.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.6 | 4.6 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.6 | 2.3 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 0.6 | 0.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.6 | 7.8 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.5 | 4.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.5 | 1.6 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 0.5 | 2.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.5 | 1.0 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
| 0.5 | 3.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 0.5 | 5.7 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.5 | 6.2 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.5 | 3.6 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 0.5 | 1.5 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.5 | 1.5 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
| 0.5 | 1.0 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.5 | 1.0 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.5 | 2.5 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
| 0.5 | 1.5 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.5 | 1.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.5 | 3.8 | GO:0090543 | Flemming body(GO:0090543) |
| 0.5 | 2.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.5 | 2.3 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.5 | 1.8 | GO:0032021 | NELF complex(GO:0032021) |
| 0.5 | 10.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.4 | 1.3 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
| 0.4 | 1.3 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.4 | 3.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.4 | 0.9 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.4 | 5.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.4 | 0.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.4 | 3.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.4 | 2.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.4 | 1.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.4 | 6.9 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.4 | 1.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.4 | 3.2 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.4 | 5.5 | GO:0070938 | contractile ring(GO:0070938) |
| 0.4 | 3.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.4 | 2.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.4 | 3.9 | GO:0001939 | female pronucleus(GO:0001939) |
| 0.4 | 1.9 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.4 | 3.8 | GO:0045120 | pronucleus(GO:0045120) |
| 0.4 | 1.1 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
| 0.4 | 3.8 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
| 0.4 | 6.0 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.4 | 4.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.4 | 1.8 | GO:0016589 | NURF complex(GO:0016589) |
| 0.4 | 8.2 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.3 | 1.0 | GO:1990423 | RZZ complex(GO:1990423) |
| 0.3 | 1.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.3 | 2.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.3 | 4.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.3 | 3.1 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.3 | 1.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.3 | 1.7 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.3 | 13.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.3 | 2.0 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.3 | 3.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.3 | 1.0 | GO:0000801 | central element(GO:0000801) |
| 0.3 | 1.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.3 | 2.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.3 | 2.8 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.3 | 3.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.3 | 4.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.3 | 1.2 | GO:0043293 | apoptosome(GO:0043293) |
| 0.3 | 2.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.3 | 2.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.3 | 0.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.3 | 6.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.3 | 4.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.3 | 2.1 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
| 0.3 | 3.8 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.3 | 0.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.3 | 2.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.3 | 5.8 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.3 | 0.3 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.3 | 1.4 | GO:0031523 | Myb complex(GO:0031523) |
| 0.3 | 0.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.3 | 1.1 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.3 | 1.1 | GO:0097574 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) |
| 0.3 | 0.8 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.3 | 23.5 | GO:0015935 | small ribosomal subunit(GO:0015935) |
| 0.3 | 1.4 | GO:0005861 | troponin complex(GO:0005861) |
| 0.3 | 1.4 | GO:0097361 | CIA complex(GO:0097361) |
| 0.3 | 1.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.3 | 0.3 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.3 | 1.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.3 | 0.8 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.3 | 1.9 | GO:0042825 | TAP complex(GO:0042825) |
| 0.3 | 2.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 0.3 | 0.8 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
| 0.3 | 3.9 | GO:0042555 | MCM complex(GO:0042555) |
| 0.3 | 1.8 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.3 | 2.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.3 | 11.9 | GO:0000791 | euchromatin(GO:0000791) |
| 0.3 | 4.9 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.3 | 2.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.3 | 3.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.3 | 18.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.2 | 1.0 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.2 | 0.7 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
| 0.2 | 1.0 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.2 | 0.5 | GO:0044299 | C-fiber(GO:0044299) |
| 0.2 | 0.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.2 | 0.2 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 0.2 | 7.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.2 | 0.7 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.2 | 0.9 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.2 | 13.2 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.2 | 3.1 | GO:0045095 | keratin filament(GO:0045095) |
| 0.2 | 1.8 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.2 | 4.8 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.2 | 0.9 | GO:0030891 | VCB complex(GO:0030891) |
| 0.2 | 0.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.2 | 2.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.2 | 1.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.2 | 2.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.2 | 1.3 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.2 | 1.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.2 | 3.7 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.2 | 1.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.2 | 0.4 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.2 | 1.9 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.2 | 0.2 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.2 | 2.4 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.2 | 1.5 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.2 | 1.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
| 0.2 | 8.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.2 | 3.2 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.2 | 1.7 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.2 | 3.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.2 | 3.3 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.2 | 1.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.2 | 0.8 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.2 | 0.8 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.2 | 3.1 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.2 | 1.2 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.2 | 1.0 | GO:0044308 | axonal spine(GO:0044308) |
| 0.2 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.2 | 0.8 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.2 | 5.4 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.2 | 0.8 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.2 | 1.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.2 | 5.5 | GO:0016592 | mediator complex(GO:0016592) |
| 0.2 | 2.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.2 | 1.4 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
| 0.2 | 8.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.2 | 0.8 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.2 | 0.8 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.2 | 0.6 | GO:0000811 | GINS complex(GO:0000811) |
| 0.2 | 3.4 | GO:0005844 | polysome(GO:0005844) |
| 0.2 | 1.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.2 | 1.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.2 | 0.7 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
| 0.2 | 18.9 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.2 | 0.2 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.2 | 0.2 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 0.2 | 0.7 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.2 | 0.6 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.2 | 0.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.2 | 9.5 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
| 0.2 | 2.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.2 | 0.7 | GO:0032127 | dense core granule membrane(GO:0032127) |
| 0.2 | 1.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.2 | 0.7 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.2 | 2.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.2 | 0.7 | GO:0071942 | XPC complex(GO:0071942) |
| 0.2 | 0.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.2 | 2.4 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.2 | 44.7 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.2 | 1.5 | GO:0005839 | proteasome core complex(GO:0005839) |
| 0.2 | 1.5 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.2 | 0.5 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.2 | 2.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.2 | 1.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.2 | 2.6 | GO:0005605 | basal lamina(GO:0005605) |
| 0.2 | 1.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.2 | 2.1 | GO:0005922 | connexon complex(GO:0005922) |
| 0.2 | 2.6 | GO:0036038 | MKS complex(GO:0036038) |
| 0.2 | 13.0 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.2 | 0.8 | GO:0072487 | MSL complex(GO:0072487) |
| 0.2 | 8.7 | GO:0031970 | organelle envelope lumen(GO:0031970) |
| 0.2 | 0.3 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.2 | 0.5 | GO:0071437 | invadopodium(GO:0071437) |
| 0.2 | 4.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.2 | 0.5 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
| 0.2 | 3.2 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.2 | 1.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.1 | 0.4 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.1 | 0.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.1 | 2.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.1 | 5.1 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.1 | 0.7 | GO:1990745 | EARP complex(GO:1990745) |
| 0.1 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.1 | 0.7 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.1 | 1.8 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.1 | 0.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 18.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.1 | 0.6 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.1 | 1.4 | GO:0098687 | chromosomal region(GO:0098687) |
| 0.1 | 2.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.1 | 0.4 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.1 | 1.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 2.6 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.1 | 0.5 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.1 | 0.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
| 0.1 | 0.7 | GO:0042599 | lamellar body(GO:0042599) |
| 0.1 | 2.1 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
| 0.1 | 0.4 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.1 | 0.3 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.1 | 1.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 33.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.1 | 2.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.1 | 0.5 | GO:0060187 | cell pole(GO:0060187) |
| 0.1 | 1.1 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.1 | 7.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.1 | 0.4 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 1.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.1 | 2.0 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.1 | 1.1 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.1 | 1.4 | GO:0033179 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.1 | 1.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.1 | 5.6 | GO:0005902 | microvillus(GO:0005902) |
| 0.1 | 0.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.1 | 0.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.1 | 1.3 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.1 | 2.3 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 1.4 | GO:0031011 | Ino80 complex(GO:0031011) |
| 0.1 | 0.4 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.1 | 0.2 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 0.1 | 0.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.1 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 0.9 | GO:0016234 | inclusion body(GO:0016234) |
| 0.1 | 1.2 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.1 | 4.9 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.1 | 1.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.1 | 38.0 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.1 | 0.3 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
| 0.1 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
| 0.1 | 0.3 | GO:0036156 | inner dynein arm(GO:0036156) |
| 0.1 | 1.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 0.4 | GO:0031415 | NatA complex(GO:0031415) |
| 0.1 | 1.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.1 | 0.1 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
| 0.1 | 0.3 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
| 0.1 | 1.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
| 0.1 | 0.6 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.1 | 0.8 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.1 | 0.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.1 | 1.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.1 | 0.5 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.1 | 0.7 | GO:0033503 | HULC complex(GO:0033503) |
| 0.1 | 0.8 | GO:0051286 | cell tip(GO:0051286) |
| 0.1 | 0.6 | GO:0034709 | methylosome(GO:0034709) |
| 0.1 | 0.3 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.1 | 1.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.1 | 0.2 | GO:0042611 | MHC protein complex(GO:0042611) |
| 0.1 | 0.1 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.1 | 5.9 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.1 | 4.0 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.1 | 0.1 | GO:0045179 | apical cortex(GO:0045179) |
| 0.1 | 3.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.1 | 1.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.1 | 2.1 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.1 | 1.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.1 | 1.1 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
| 0.1 | 0.4 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.1 | 1.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.1 | 0.3 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.1 | 4.1 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.1 | 0.7 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 0.1 | 0.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.1 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.1 | 0.2 | GO:0005775 | vacuolar lumen(GO:0005775) |
| 0.1 | 0.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.1 | 0.2 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.1 | 0.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.1 | 0.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.1 | 1.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 0.1 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
| 0.1 | 1.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.1 | 0.3 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.1 | 2.2 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.1 | 0.3 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.1 | 0.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 4.6 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
| 0.1 | 0.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 0.1 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.1 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.1 | 0.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.1 | 0.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.1 | 0.2 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.1 | 0.1 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
| 0.1 | 0.1 | GO:0070461 | SAGA-type complex(GO:0070461) |
| 0.1 | 0.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.1 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.1 | 1.3 | GO:0005657 | replication fork(GO:0005657) |
| 0.1 | 0.5 | GO:0001741 | XY body(GO:0001741) |
| 0.1 | 0.7 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.1 | 0.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.1 | 0.9 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.0 | 0.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.0 | 1.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.0 | 0.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.0 | 0.8 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.0 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.0 | 0.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.0 | 0.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.0 | 0.2 | GO:0043218 | compact myelin(GO:0043218) |
| 0.0 | 0.3 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
| 0.0 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.0 | 1.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.0 | 0.2 | GO:0008623 | CHRAC(GO:0008623) |
| 0.0 | 0.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.0 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.0 | 1.1 | GO:0097546 | ciliary base(GO:0097546) |
| 0.0 | 0.1 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.0 | 0.2 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.0 | 0.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.0 | 0.1 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
| 0.0 | 2.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 0.2 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.0 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.0 | 0.3 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.0 | 0.0 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.0 | 0.8 | GO:0030904 | retromer complex(GO:0030904) |
| 0.0 | 0.3 | GO:0044754 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
| 0.0 | 0.0 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
| 0.0 | 0.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.0 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
| 0.0 | 0.2 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.0 | 2.1 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.0 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 0.2 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
| 0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
| 0.0 | 0.2 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.0 | 56.4 | GO:0070062 | extracellular exosome(GO:0070062) |
| 0.0 | 4.0 | GO:0000790 | nuclear chromatin(GO:0000790) |
| 0.0 | 0.5 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.0 | 0.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.0 | 0.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.0 | 0.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.0 | 0.2 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.0 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 0.3 | GO:0000922 | spindle pole(GO:0000922) |
| 0.0 | 0.5 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.0 | 0.1 | GO:0061702 | inflammasome complex(GO:0061702) |
| 0.0 | 0.2 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.0 | 0.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.0 | 0.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
| 0.0 | 0.1 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.0 | 0.3 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 0.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.0 | 8.0 | GO:0005739 | mitochondrion(GO:0005739) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.8 | 8.8 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 1.7 | 5.2 | GO:0035939 | microsatellite binding(GO:0035939) |
| 1.7 | 5.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 1.5 | 5.9 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 1.5 | 4.4 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
| 1.5 | 5.9 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 1.4 | 7.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
| 1.4 | 2.7 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
| 1.3 | 4.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 1.2 | 6.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 1.2 | 3.5 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
| 1.2 | 5.8 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 1.2 | 6.9 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 1.1 | 4.2 | GO:1990254 | keratin filament binding(GO:1990254) |
| 1.1 | 6.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 1.1 | 3.2 | GO:0070052 | collagen V binding(GO:0070052) |
| 1.0 | 5.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 1.0 | 3.0 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 1.0 | 3.0 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
| 1.0 | 3.9 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 1.0 | 2.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.9 | 3.7 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
| 0.9 | 5.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.9 | 8.0 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.9 | 2.6 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.8 | 2.5 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 0.8 | 2.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
| 0.8 | 5.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
| 0.8 | 2.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.8 | 4.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
| 0.8 | 7.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.8 | 3.2 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.8 | 2.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.8 | 3.2 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.8 | 3.9 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.8 | 2.3 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
| 0.8 | 1.5 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.8 | 6.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.7 | 3.0 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
| 0.7 | 4.5 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
| 0.7 | 4.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.7 | 10.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.7 | 2.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.7 | 2.8 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.7 | 4.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.7 | 2.8 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.7 | 5.5 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.7 | 2.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.7 | 2.0 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.7 | 2.0 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
| 0.7 | 2.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.7 | 2.0 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.7 | 2.0 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.6 | 1.9 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
| 0.6 | 1.9 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.6 | 1.9 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 0.6 | 3.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.6 | 2.5 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.6 | 1.9 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 0.6 | 3.1 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.6 | 2.4 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.6 | 7.9 | GO:0031386 | protein tag(GO:0031386) |
| 0.6 | 5.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.6 | 0.6 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.6 | 3.0 | GO:1990188 | euchromatin binding(GO:1990188) |
| 0.6 | 3.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.6 | 5.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.6 | 2.9 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.6 | 1.8 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
| 0.6 | 4.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.6 | 1.7 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.6 | 1.7 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 0.6 | 1.7 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.6 | 1.7 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
| 0.6 | 1.7 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.6 | 1.7 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
| 0.6 | 2.8 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.6 | 3.3 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.6 | 2.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
| 0.5 | 3.8 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.5 | 0.5 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
| 0.5 | 4.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.5 | 3.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.5 | 2.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.5 | 4.9 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.5 | 9.1 | GO:0051861 | glycolipid binding(GO:0051861) |
| 0.5 | 3.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.5 | 1.6 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.5 | 2.1 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 0.5 | 2.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) phospholipase A2 inhibitor activity(GO:0019834) |
| 0.5 | 4.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.5 | 2.1 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
| 0.5 | 1.5 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
| 0.5 | 1.5 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.5 | 2.6 | GO:0005534 | galactose binding(GO:0005534) |
| 0.5 | 1.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.5 | 1.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.5 | 4.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.5 | 1.5 | GO:0001565 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
| 0.5 | 1.5 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.5 | 2.0 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
| 0.5 | 1.5 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
| 0.5 | 3.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.5 | 6.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.5 | 4.8 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
| 0.5 | 2.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.5 | 6.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.5 | 3.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.5 | 5.1 | GO:0008430 | selenium binding(GO:0008430) |
| 0.5 | 1.4 | GO:0018738 | S-formylglutathione hydrolase activity(GO:0018738) |
| 0.5 | 0.5 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.5 | 7.8 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.5 | 1.4 | GO:0070140 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
| 0.4 | 3.6 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.4 | 3.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.4 | 1.3 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
| 0.4 | 1.3 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
| 0.4 | 2.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.4 | 1.3 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.4 | 1.8 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.4 | 3.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.4 | 3.5 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.4 | 6.1 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
| 0.4 | 6.9 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.4 | 17.8 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.4 | 0.8 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
| 0.4 | 3.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.4 | 1.7 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.4 | 1.7 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.4 | 4.1 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.4 | 1.6 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.4 | 2.9 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.4 | 1.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.4 | 1.6 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.4 | 1.2 | GO:0017084 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
| 0.4 | 2.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.4 | 2.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.4 | 0.4 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.4 | 3.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.4 | 3.5 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.4 | 0.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.4 | 7.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.4 | 1.6 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.4 | 2.3 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
| 0.4 | 1.2 | GO:0051870 | methotrexate binding(GO:0051870) |
| 0.4 | 1.9 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.4 | 1.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.4 | 1.9 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 0.4 | 5.3 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.4 | 1.1 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.4 | 1.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.4 | 4.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.4 | 1.5 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.4 | 7.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.4 | 4.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.4 | 2.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.4 | 1.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.4 | 1.1 | GO:0005118 | sevenless binding(GO:0005118) |
| 0.4 | 5.4 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
| 0.4 | 1.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.4 | 3.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.4 | 1.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.4 | 1.4 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.4 | 1.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.4 | 1.4 | GO:0035473 | lipase binding(GO:0035473) |
| 0.4 | 1.4 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 0.4 | 1.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
| 0.4 | 0.4 | GO:0035877 | death effector domain binding(GO:0035877) |
| 0.3 | 0.3 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.3 | 1.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.3 | 2.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.3 | 6.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 0.3 | 1.0 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
| 0.3 | 2.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.3 | 2.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.3 | 3.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.3 | 1.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.3 | 1.0 | GO:0036004 | GAF domain binding(GO:0036004) |
| 0.3 | 0.3 | GO:0001179 | RNA polymerase I transcription factor binding(GO:0001179) |
| 0.3 | 1.3 | GO:0042806 | fucose binding(GO:0042806) |
| 0.3 | 1.3 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 0.3 | 1.3 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
| 0.3 | 0.3 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 0.3 | 7.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.3 | 1.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.3 | 1.3 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.3 | 5.8 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.3 | 1.0 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
| 0.3 | 2.2 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.3 | 1.0 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
| 0.3 | 0.3 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 0.3 | 2.5 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.3 | 0.9 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.3 | 0.3 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
| 0.3 | 2.2 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.3 | 1.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.3 | 0.9 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.3 | 0.9 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.3 | 1.6 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
| 0.3 | 2.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.3 | 1.9 | GO:1990715 | mRNA CDS binding(GO:1990715) |
| 0.3 | 1.5 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
| 0.3 | 0.3 | GO:0070404 | NADH binding(GO:0070404) |
| 0.3 | 3.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.3 | 0.3 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.3 | 2.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.3 | 1.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.3 | 2.1 | GO:0015099 | nickel cation transmembrane transporter activity(GO:0015099) |
| 0.3 | 1.2 | GO:0070976 | TIR domain binding(GO:0070976) |
| 0.3 | 1.8 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.3 | 5.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.3 | 0.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.3 | 16.1 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
| 0.3 | 1.5 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
| 0.3 | 0.9 | GO:0034618 | arginine binding(GO:0034618) |
| 0.3 | 1.7 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.3 | 6.4 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.3 | 2.6 | GO:0070513 | death domain binding(GO:0070513) |
| 0.3 | 2.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.3 | 0.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.3 | 1.1 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.3 | 3.4 | GO:0005522 | profilin binding(GO:0005522) |
| 0.3 | 1.1 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.3 | 9.8 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.3 | 2.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.3 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
| 0.3 | 0.8 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.3 | 1.4 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
| 0.3 | 1.4 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.3 | 1.4 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.3 | 3.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.3 | 1.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.3 | 0.3 | GO:0003681 | bent DNA binding(GO:0003681) |
| 0.3 | 2.4 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
| 0.3 | 0.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.3 | 1.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.3 | 2.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.3 | 2.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.3 | 0.8 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 0.3 | 2.9 | GO:0043495 | protein anchor(GO:0043495) |
| 0.3 | 0.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.3 | 1.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.3 | 9.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.3 | 10.9 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.3 | 0.8 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.3 | 1.0 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.3 | 42.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.3 | 0.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 0.3 | 2.5 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
| 0.3 | 1.3 | GO:0042165 | neurotransmitter binding(GO:0042165) |
| 0.3 | 4.3 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.3 | 1.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.2 | 0.7 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.2 | 4.4 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.2 | 1.7 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.2 | 1.0 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.2 | 9.5 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.2 | 0.7 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.2 | 1.0 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.2 | 0.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.2 | 0.5 | GO:0030983 | mismatched DNA binding(GO:0030983) |
| 0.2 | 1.7 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.2 | 1.4 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.2 | 1.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.2 | 3.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.2 | 2.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.2 | 3.0 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.2 | 1.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.2 | 0.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.2 | 10.7 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.2 | 0.4 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.2 | 12.7 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.2 | 0.7 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.2 | 4.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.2 | 4.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.2 | 0.4 | GO:0046977 | TAP binding(GO:0046977) |
| 0.2 | 0.7 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.2 | 0.9 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
| 0.2 | 2.2 | GO:0070888 | E-box binding(GO:0070888) |
| 0.2 | 7.5 | GO:0005112 | Notch binding(GO:0005112) |
| 0.2 | 0.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.2 | 1.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.2 | 1.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.2 | 0.9 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.2 | 1.1 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) protein binding involved in cell-cell adhesion(GO:0098632) |
| 0.2 | 1.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) glycerol transmembrane transporter activity(GO:0015168) |
| 0.2 | 1.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.2 | 0.6 | GO:0070061 | fructose binding(GO:0070061) |
| 0.2 | 0.8 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
| 0.2 | 0.4 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 0.2 | 1.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.2 | 2.1 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.2 | 0.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.2 | 1.0 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.2 | 0.6 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
| 0.2 | 0.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.2 | 8.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.2 | 0.4 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
| 0.2 | 0.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.2 | 0.6 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.2 | 0.8 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.2 | 3.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.2 | 1.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.2 | 1.0 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.2 | 6.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.2 | 4.5 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.2 | 2.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.2 | 0.6 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.2 | 2.7 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.2 | 0.8 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
| 0.2 | 2.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.2 | 3.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.2 | 1.2 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
| 0.2 | 0.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.2 | 0.6 | GO:0005110 | frizzled-2 binding(GO:0005110) |
| 0.2 | 0.6 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 0.2 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.2 | 0.8 | GO:2001069 | glycogen binding(GO:2001069) |
| 0.2 | 0.9 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.2 | 0.8 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.2 | 3.0 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.2 | 2.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.2 | 0.6 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.2 | 0.2 | GO:0032356 | oxidized DNA binding(GO:0032356) |
| 0.2 | 0.7 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.2 | 0.9 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.2 | 0.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.2 | 1.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.2 | 0.4 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 0.2 | 0.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.2 | 1.1 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.2 | 1.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.2 | 0.4 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.2 | 0.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.2 | 2.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.2 | 4.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.2 | 3.9 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.2 | 0.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.2 | 0.5 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.2 | 0.9 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.2 | 1.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.2 | 1.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.2 | 0.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.2 | 1.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.2 | 3.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.2 | 0.7 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
| 0.2 | 1.0 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
| 0.2 | 1.7 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.2 | 3.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.2 | 0.7 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
| 0.2 | 0.7 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.2 | 0.7 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.2 | 1.2 | GO:0008198 | ferrous iron binding(GO:0008198) |
| 0.2 | 0.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.2 | 3.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.2 | 3.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.2 | 1.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.2 | 3.7 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
| 0.2 | 1.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.2 | 0.5 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.2 | 1.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.2 | 1.5 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.2 | 0.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.2 | 2.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.2 | 1.6 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.2 | 2.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.2 | 1.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.2 | 1.7 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.2 | 1.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.2 | 0.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.2 | 3.2 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.2 | 0.6 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.2 | 6.8 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
| 0.2 | 6.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.2 | 1.2 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.2 | 1.1 | GO:0015925 | galactosidase activity(GO:0015925) |
| 0.2 | 0.3 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.2 | 1.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.1 | 0.6 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.1 | 0.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.1 | 0.7 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.1 | 1.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.1 | 1.4 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.1 | 0.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.1 | 1.0 | GO:0015288 | porin activity(GO:0015288) |
| 0.1 | 0.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
| 0.1 | 1.7 | GO:0048038 | quinone binding(GO:0048038) |
| 0.1 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.1 | 10.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 0.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.1 | 1.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.1 | 0.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.1 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
| 0.1 | 1.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.1 | 0.7 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.1 | 1.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.1 | 0.4 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
| 0.1 | 1.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.1 | 1.7 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.1 | 0.4 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.1 | 0.5 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.1 | 0.6 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 0.1 | 1.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 0.3 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
| 0.1 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.1 | 0.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.1 | 1.3 | GO:0048185 | activin binding(GO:0048185) |
| 0.1 | 1.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.1 | 0.5 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
| 0.1 | 1.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.1 | 0.4 | GO:0046403 | polynucleotide 3'-phosphatase activity(GO:0046403) |
| 0.1 | 1.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.1 | 1.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.1 | 0.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.1 | 1.6 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
| 0.1 | 0.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.1 | 0.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.1 | 0.7 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
| 0.1 | 0.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.1 | 1.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.1 | 1.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 0.5 | GO:0070538 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) oleic acid binding(GO:0070538) phosphatidylethanolamine transporter activity(GO:1904121) |
| 0.1 | 1.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.1 | 1.3 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.1 | 0.8 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.1 | 0.5 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.1 | 1.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.1 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.1 | 0.9 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.1 | 0.2 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.1 | 6.8 | GO:0019003 | GDP binding(GO:0019003) |
| 0.1 | 0.2 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 0.1 | 0.3 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
| 0.1 | 0.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.1 | 0.6 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.1 | 0.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 0.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.1 | 0.2 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 0.1 | 6.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.1 | 0.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.1 | 0.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.1 | 0.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 0.1 | 0.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.1 | 2.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 1.2 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.1 | 2.5 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
| 0.1 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.1 | 1.0 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 0.1 | 1.1 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.1 | 0.4 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
| 0.1 | 0.4 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
| 0.1 | 1.7 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.1 | 7.5 | GO:0004540 | ribonuclease activity(GO:0004540) |
| 0.1 | 2.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.1 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 0.1 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.1 | 0.7 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
| 0.1 | 0.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.1 | 0.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.1 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.1 | 1.0 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
| 0.1 | 0.5 | GO:0090079 | translation repressor activity, nucleic acid binding(GO:0000900) translation regulator activity, nucleic acid binding(GO:0090079) |
| 0.1 | 5.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.1 | 0.1 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) |
| 0.1 | 12.6 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.1 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.1 | 0.9 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
| 0.1 | 1.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 0.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.1 | 0.3 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.1 | 0.3 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
| 0.1 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.1 | 0.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.1 | 0.4 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 0.1 | 0.2 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.1 | 1.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.1 | 1.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.1 | 0.4 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.1 | 0.3 | GO:0004454 | ketohexokinase activity(GO:0004454) |
| 0.1 | 0.9 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
| 0.1 | 0.5 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
| 0.1 | 0.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.1 | 44.2 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) |
| 0.1 | 0.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.1 | 0.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.1 | 2.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.1 | 0.8 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.1 | 0.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.1 | 0.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.1 | 0.4 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
| 0.1 | 0.3 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.1 | 3.3 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
| 0.1 | 0.5 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 0.1 | 0.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.1 | 0.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.1 | 0.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.1 | 0.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.1 | 0.3 | GO:0003678 | DNA helicase activity(GO:0003678) |
| 0.1 | 0.7 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.1 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.1 | 0.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.1 | 0.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.1 | 1.6 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.1 | 0.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.1 | 0.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.1 | 3.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.1 | 0.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 0.5 | GO:1901612 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
| 0.1 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
| 0.1 | 1.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.1 | 0.5 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.1 | 0.2 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.1 | 0.2 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.1 | 0.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.1 | 0.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
| 0.1 | 0.3 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.1 | 1.7 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.1 | 0.5 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.1 | 0.4 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.1 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.1 | 3.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 0.7 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.1 | 3.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 0.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.1 | 0.6 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.1 | 0.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.1 | 0.2 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
| 0.1 | 0.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.1 | 1.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
| 0.1 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.1 | 0.5 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.1 | 0.9 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.1 | 0.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.1 | 0.3 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.1 | 0.3 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 0.1 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.1 | 0.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.1 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.1 | 5.5 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
| 0.1 | 0.1 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 0.1 | 0.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
| 0.1 | 0.3 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
| 0.1 | 1.4 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.1 | 0.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.1 | 0.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.1 | 0.2 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.1 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 0.2 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
| 0.1 | 0.1 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.1 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.1 | 0.3 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
| 0.1 | 7.2 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.1 | 0.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.1 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.0 | 1.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.0 | 0.3 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
| 0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.0 | 1.0 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.0 | 0.2 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.0 | 0.5 | GO:0016208 | AMP binding(GO:0016208) |
| 0.0 | 0.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.0 | 4.3 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.0 | 0.2 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.0 | 0.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.0 | 1.6 | GO:0002020 | protease binding(GO:0002020) |
| 0.0 | 0.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.0 | 0.1 | GO:0051747 | cytosine C-5 DNA demethylase activity(GO:0051747) |
| 0.0 | 0.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.0 | 0.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.0 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.0 | 0.3 | GO:0051184 | cofactor transporter activity(GO:0051184) |
| 0.0 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.0 | 0.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.0 | 0.0 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.0 | 0.1 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
| 0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.0 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.0 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.0 | 0.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.0 | 0.7 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
| 0.0 | 0.1 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
| 0.0 | 1.4 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 0.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.0 | 0.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.0 | 0.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.0 | 0.2 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.0 | 0.4 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.0 | 0.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
| 0.0 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.0 | 0.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.0 | 0.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
| 0.0 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
| 0.0 | 1.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.0 | 0.1 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.0 | 0.1 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.0 | 3.4 | GO:0003713 | transcription coactivator activity(GO:0003713) |
| 0.0 | 0.1 | GO:0052740 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 0.0 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.0 | 0.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.0 | 0.0 | GO:0001083 | transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) |
| 0.0 | 0.2 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.0 | 0.1 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.0 | 0.0 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.0 | 0.3 | GO:0005537 | mannose binding(GO:0005537) |
| 0.0 | 0.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.0 | 0.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.0 | 0.1 | GO:0004954 | icosanoid receptor activity(GO:0004953) prostanoid receptor activity(GO:0004954) prostaglandin receptor activity(GO:0004955) |
| 0.0 | 0.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.0 | 0.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.0 | 0.0 | GO:0035514 | DNA demethylase activity(GO:0035514) |
| 0.0 | 0.0 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.0 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.0 | 0.1 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.0 | 0.1 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.0 | 0.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.0 | 0.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.0 | 0.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.0 | 1.4 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.0 | 0.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.0 | 0.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
| 0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.0 | 0.1 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.0 | 0.0 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.0 | 0.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.0 | 0.1 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.0 | 0.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
| 0.0 | 0.0 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
| 0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.0 | 0.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
| 0.0 | 0.0 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.0 | 0.0 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.0 | 0.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.0 | 0.0 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.0 | 0.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.0 | 0.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.0 | 0.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 19.4 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.6 | 0.6 | SA_B_CELL_RECEPTOR_COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.5 | 9.1 | ST_STAT3_PATHWAY | STAT3 Pathway |
| 0.5 | 4.0 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.5 | 2.5 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
| 0.5 | 2.9 | PID_S1P_S1P2_PATHWAY | S1P2 pathway |
| 0.5 | 13.5 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.4 | 3.5 | PID_INTEGRIN4_PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.4 | 3.6 | PID_IL23_PATHWAY | IL23-mediated signaling events |
| 0.4 | 16.3 | PID_FOXM1_PATHWAY | FOXM1 transcription factor network |
| 0.4 | 3.1 | SA_G1_AND_S_PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.4 | 11.4 | PID_WNT_SIGNALING_PATHWAY | Wnt signaling network |
| 0.4 | 6.4 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
| 0.4 | 19.0 | PID_HES_HEY_PATHWAY | Notch-mediated HES/HEY network |
| 0.3 | 2.3 | PID_IL5_PATHWAY | IL5-mediated signaling events |
| 0.3 | 24.6 | PID_HDAC_CLASSI_PATHWAY | Signaling events mediated by HDAC Class I |
| 0.3 | 8.9 | NABA_BASEMENT_MEMBRANES | Genes encoding structural components of basement membranes |
| 0.3 | 17.2 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
| 0.3 | 1.6 | PID_ALK1_PATHWAY | ALK1 signaling events |
| 0.3 | 13.5 | PID_INTEGRIN1_PATHWAY | Beta1 integrin cell surface interactions |
| 0.3 | 0.3 | ST_ADRENERGIC | Adrenergic Pathway |
| 0.3 | 17.1 | PID_PLK1_PATHWAY | PLK1 signaling events |
| 0.3 | 3.6 | PID_EPHA2_FWD_PATHWAY | EPHA2 forward signaling |
| 0.3 | 0.6 | PID_IL3_PATHWAY | IL3-mediated signaling events |
| 0.3 | 9.8 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.3 | 3.8 | PID_ANTHRAX_PATHWAY | Cellular roles of Anthrax toxin |
| 0.3 | 10.2 | PID_HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.3 | 6.4 | PID_P38_MK2_PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.3 | 10.6 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
| 0.3 | 3.8 | PID_PRL_SIGNALING_EVENTS_PATHWAY | Signaling events mediated by PRL |
| 0.3 | 1.9 | PID_LYMPH_ANGIOGENESIS_PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.3 | 1.6 | PID_IL12_STAT4_PATHWAY | IL12 signaling mediated by STAT4 |
| 0.3 | 0.5 | ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.3 | 10.3 | PID_HNF3B_PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.3 | 0.8 | PID_PS1_PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.2 | 3.0 | PID_ECADHERIN_KERATINOCYTE_PATHWAY | E-cadherin signaling in keratinocytes |
| 0.2 | 0.7 | PID_NFAT_3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.2 | 6.0 | PID_P38_ALPHA_BETA_PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.2 | 20.6 | PID_MYC_ACTIV_PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.2 | 1.1 | PID_AR_NONGENOMIC_PATHWAY | Nongenotropic Androgen signaling |
| 0.2 | 5.2 | PID_IGF1_PATHWAY | IGF1 pathway |
| 0.2 | 0.6 | ST_INTERFERON_GAMMA_PATHWAY | Interferon gamma pathway. |
| 0.2 | 8.4 | PID_SMAD2_3NUCLEAR_PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.2 | 6.3 | PID_ATR_PATHWAY | ATR signaling pathway |
| 0.2 | 2.2 | PID_NFKAPPAB_ATYPICAL_PATHWAY | Atypical NF-kappaB pathway |
| 0.2 | 2.2 | PID_PDGFRA_PATHWAY | PDGFR-alpha signaling pathway |
| 0.2 | 2.0 | PID_MYC_PATHWAY | C-MYC pathway |
| 0.2 | 1.4 | ST_PAC1_RECEPTOR_PATHWAY | PAC1 Receptor Pathway |
| 0.2 | 6.1 | PID_IL12_2PATHWAY | IL12-mediated signaling events |
| 0.2 | 7.2 | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.2 | 5.2 | PID_HEDGEHOG_2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.2 | 2.0 | PID_RET_PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.2 | 3.8 | PID_TCR_CALCIUM_PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.2 | 0.4 | PID_PI3K_PLC_TRK_PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.2 | 1.7 | PID_WNT_NONCANONICAL_PATHWAY | Noncanonical Wnt signaling pathway |
| 0.2 | 2.6 | PID_AURORA_A_PATHWAY | Aurora A signaling |
| 0.2 | 1.6 | ST_GRANULE_CELL_SURVIVAL_PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.2 | 12.7 | WNT_SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.2 | 4.7 | PID_AR_TF_PATHWAY | Regulation of Androgen receptor activity |
| 0.2 | 2.2 | PID_ALPHA_SYNUCLEIN_PATHWAY | Alpha-synuclein signaling |
| 0.2 | 1.1 | PID_AVB3_INTEGRIN_PATHWAY | Integrins in angiogenesis |
| 0.1 | 1.5 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
| 0.1 | 4.0 | PID_E2F_PATHWAY | E2F transcription factor network |
| 0.1 | 3.2 | PID_BARD1_PATHWAY | BARD1 signaling events |
| 0.1 | 1.4 | PID_HDAC_CLASSII_PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 0.7 | PID_S1P_S1P3_PATHWAY | S1P3 pathway |
| 0.1 | 4.2 | PID_AURORA_B_PATHWAY | Aurora B signaling |
| 0.1 | 2.4 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
| 0.1 | 7.3 | PID_P73PATHWAY | p73 transcription factor network |
| 0.1 | 4.3 | PID_RHOA_PATHWAY | RhoA signaling pathway |
| 0.1 | 5.1 | PID_CMYB_PATHWAY | C-MYB transcription factor network |
| 0.1 | 0.6 | SA_MMP_CYTOKINE_CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.1 | 3.3 | PID_AP1_PATHWAY | AP-1 transcription factor network |
| 0.1 | 0.2 | PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY | EGF receptor (ErbB1) signaling pathway |
| 0.1 | 0.1 | PID_P38_GAMMA_DELTA_PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.1 | 2.9 | PID_SYNDECAN_1_PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 0.8 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 1.4 | PID_DELTA_NP63_PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.1 | 1.4 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 0.5 | SA_FAS_SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.1 | 3.4 | PID_BMP_PATHWAY | BMP receptor signaling |
| 0.1 | 2.6 | PID_HEDGEHOG_GLI_PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.1 | 0.9 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 0.9 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 0.7 | ST_G_ALPHA_S_PATHWAY | G alpha s Pathway |
| 0.1 | 3.7 | PID_ERA_GENOMIC_PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.1 | 5.2 | PID_RAC1_REG_PATHWAY | Regulation of RAC1 activity |
| 0.1 | 2.3 | PID_TAP63_PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 0.7 | PID_EPO_PATHWAY | EPO signaling pathway |
| 0.1 | 2.1 | PID_ECADHERIN_STABILIZATION_PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.1 | 0.8 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
| 0.1 | 0.6 | PID_S1P_META_PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.1 | 1.5 | PID_TRAIL_PATHWAY | TRAIL signaling pathway |
| 0.1 | 1.4 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
| 0.1 | 0.1 | ST_WNT_CA2_CYCLIC_GMP_PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.1 | 1.8 | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | Genes related to the insulin receptor pathway |
| 0.1 | 1.7 | PID_EPHB_FWD_PATHWAY | EPHB forward signaling |
| 0.1 | 0.3 | ST_P38_MAPK_PATHWAY | p38 MAPK Pathway |
| 0.1 | 1.0 | PID_DNA_PK_PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.1 | 0.6 | PID_PTP1B_PATHWAY | Signaling events mediated by PTP1B |
| 0.1 | 0.8 | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.1 | 2.4 | PID_AR_PATHWAY | Coregulation of Androgen receptor activity |
| 0.1 | 1.3 | PID_FGF_PATHWAY | FGF signaling pathway |
| 0.1 | 0.5 | PID_CXCR3_PATHWAY | CXCR3-mediated signaling events |
| 0.1 | 2.2 | PID_NOTCH_PATHWAY | Notch signaling pathway |
| 0.0 | 1.0 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 4.3 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 1.2 | PID_CASPASE_PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 3.5 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 0.6 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.0 | 0.9 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.0 | 0.3 | PID_ERBB2_ERBB3_PATHWAY | ErbB2/ErbB3 signaling events |
| 0.0 | 0.7 | PID_MYC_REPRESS_PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 0.2 | PID_AJDISS_2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 0.1 | PID_WNT_CANONICAL_PATHWAY | Canonical Wnt signaling pathway |
| 0.0 | 0.1 | PID_A6B1_A6B4_INTEGRIN_PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.0 | 0.2 | ST_WNT_BETA_CATENIN_PATHWAY | Wnt/beta-catenin Pathway |
| 0.0 | 0.3 | PID_FANCONI_PATHWAY | Fanconi anemia pathway |
| 0.0 | 0.2 | PID_NFAT_TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 0.1 | PID_VEGFR1_2_PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.0 | 0.0 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.0 | 0.6 | PID_P53_REGULATION_PATHWAY | p53 pathway |
| 0.0 | 0.0 | PID_TCR_JNK_PATHWAY | JNK signaling in the CD4+ TCR pathway |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.1 | 4.3 | REACTOME_ETHANOL_OXIDATION | Genes involved in Ethanol oxidation |
| 0.7 | 19.3 | REACTOME_G0_AND_EARLY_G1 | Genes involved in G0 and Early G1 |
| 0.7 | 0.7 | REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.7 | 0.7 | REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.7 | 11.3 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.7 | 8.0 | REACTOME_IL_6_SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.7 | 0.7 | REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
| 0.7 | 9.1 | REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.6 | 1.9 | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.6 | 0.6 | REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.6 | 3.6 | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.6 | 4.6 | REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.5 | 11.0 | REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.5 | 8.3 | REACTOME_METABOLISM_OF_POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.5 | 5.7 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
| 0.5 | 5.5 | REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.5 | 8.1 | REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
| 0.5 | 3.8 | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.5 | 9.2 | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.4 | 4.9 | REACTOME_RAF_MAP_KINASE_CASCADE | Genes involved in RAF/MAP kinase cascade |
| 0.4 | 0.9 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.4 | 7.5 | REACTOME_P38MAPK_EVENTS | Genes involved in p38MAPK events |
| 0.4 | 6.6 | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.4 | 10.7 | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.4 | 0.4 | REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.4 | 11.7 | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.4 | 0.4 | REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.4 | 4.4 | REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.4 | 1.6 | REACTOME_INFLUENZA_LIFE_CYCLE | Genes involved in Influenza Life Cycle |
| 0.4 | 3.9 | REACTOME_LIPOPROTEIN_METABOLISM | Genes involved in Lipoprotein metabolism |
| 0.4 | 3.5 | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.4 | 16.0 | REACTOME_GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.4 | 0.8 | REACTOME_IL_7_SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.4 | 12.0 | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PLC_BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.4 | 0.4 | REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 0.4 | 2.6 | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.4 | 2.2 | REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 0.4 | 1.8 | REACTOME_SIGNALING_BY_FGFR | Genes involved in Signaling by FGFR |
| 0.3 | 1.7 | REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.3 | 2.7 | REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.3 | 2.7 | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.3 | 5.4 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.3 | 2.7 | REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION | Genes involved in RORA Activates Circadian Expression |
| 0.3 | 3.3 | REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.3 | 33.9 | REACTOME_PEPTIDE_CHAIN_ELONGATION | Genes involved in Peptide chain elongation |
| 0.3 | 8.7 | REACTOME_KINESINS | Genes involved in Kinesins |
| 0.3 | 11.6 | REACTOME_G1_PHASE | Genes involved in G1 Phase |
| 0.3 | 6.5 | REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
| 0.3 | 9.9 | REACTOME_TIGHT_JUNCTION_INTERACTIONS | Genes involved in Tight junction interactions |
| 0.3 | 2.4 | REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 0.3 | 5.7 | REACTOME_SIGNAL_ATTENUATION | Genes involved in Signal attenuation |
| 0.3 | 4.6 | REACTOME_UNWINDING_OF_DNA | Genes involved in Unwinding of DNA |
| 0.3 | 26.6 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_ | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 0.3 | 5.8 | REACTOME_HS_GAG_DEGRADATION | Genes involved in HS-GAG degradation |
| 0.3 | 2.9 | REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 0.3 | 4.8 | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.3 | 4.8 | REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.3 | 0.8 | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.3 | 0.5 | REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.3 | 23.3 | REACTOME_MITOTIC_PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.2 | 7.5 | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.2 | 5.5 | REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.2 | 2.9 | REACTOME_ER_PHAGOSOME_PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.2 | 6.1 | REACTOME_STRIATED_MUSCLE_CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.2 | 0.2 | REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE | Genes involved in Early Phase of HIV Life Cycle |
| 0.2 | 2.8 | REACTOME_GAP_JUNCTION_ASSEMBLY | Genes involved in Gap junction assembly |
| 0.2 | 5.2 | REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.2 | 5.2 | REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.2 | 10.9 | REACTOME_RNA_POL_I_PROMOTER_OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.2 | 1.7 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.2 | 1.7 | REACTOME_SULFUR_AMINO_ACID_METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.2 | 1.1 | REACTOME_ANDROGEN_BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.2 | 1.3 | REACTOME_DSCAM_INTERACTIONS | Genes involved in DSCAM interactions |
| 0.2 | 11.8 | REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.2 | 10.7 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.2 | 4.1 | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.2 | 3.7 | REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.2 | 1.4 | REACTOME_G1_S_SPECIFIC_TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.2 | 1.6 | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | Genes involved in Signal transduction by L1 |
| 0.2 | 3.9 | REACTOME_PYRIMIDINE_METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.2 | 2.3 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.2 | 9.3 | REACTOME_PHASE_II_CONJUGATION | Genes involved in Phase II conjugation |
| 0.2 | 1.3 | REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.2 | 4.9 | REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.2 | 1.9 | REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.2 | 11.7 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.2 | 1.5 | REACTOME_STEROID_HORMONES | Genes involved in Steroid hormones |
| 0.2 | 5.0 | REACTOME_BASIGIN_INTERACTIONS | Genes involved in Basigin interactions |
| 0.2 | 1.4 | REACTOME_TRYPTOPHAN_CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.2 | 2.0 | REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.2 | 4.5 | REACTOME_MYOGENESIS | Genes involved in Myogenesis |
| 0.2 | 4.1 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 0.6 | REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.1 | 24.6 | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.1 | 0.7 | REACTOME_ELONGATION_ARREST_AND_RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.1 | 2.4 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 3.0 | REACTOME_METABOLISM_OF_PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 0.3 | REACTOME_ARMS_MEDIATED_ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.1 | 3.0 | REACTOME_MICRORNA_MIRNA_BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.1 | 0.5 | REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
| 0.1 | 1.3 | REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.1 | 2.2 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.1 | 2.1 | REACTOME_MUSCLE_CONTRACTION | Genes involved in Muscle contraction |
| 0.1 | 11.4 | REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.1 | 6.1 | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 1.3 | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.1 | 0.6 | REACTOME_PACKAGING_OF_TELOMERE_ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 2.0 | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.1 | 1.2 | REACTOME_AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 8.3 | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.1 | 5.0 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.1 | 1.0 | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.1 | 2.6 | REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.1 | 0.9 | REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.1 | 0.1 | REACTOME_BOTULINUM_NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
| 0.1 | 0.7 | REACTOME_THE_NLRP3_INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.1 | 0.8 | REACTOME_M_G1_TRANSITION | Genes involved in M/G1 Transition |
| 0.1 | 2.3 | REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.1 | 0.4 | REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.1 | 1.5 | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.1 | 2.4 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.1 | 5.0 | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.1 | 1.8 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.1 | 0.2 | REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.1 | 2.1 | REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.1 | 0.2 | REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.1 | 3.4 | REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
| 0.1 | 2.1 | REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.1 | 0.3 | REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.1 | 0.8 | REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER | Genes involved in Formation of incision complex in GG-NER |
| 0.1 | 1.4 | REACTOME_PIP3_ACTIVATES_AKT_SIGNALING | Genes involved in PIP3 activates AKT signaling |
| 0.1 | 5.8 | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.1 | 1.8 | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.1 | 1.8 | REACTOME_METABOLISM_OF_NON_CODING_RNA | Genes involved in Metabolism of non-coding RNA |
| 0.1 | 1.0 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.1 | 0.3 | REACTOME_INTRINSIC_PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 2.0 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.1 | 0.4 | REACTOME_REGULATION_OF_KIT_SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.1 | 0.1 | REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.1 | 1.3 | REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.1 | 0.1 | REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.1 | 0.3 | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.1 | 1.5 | REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.1 | 0.6 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.1 | 3.4 | REACTOME_TRANSLATION | Genes involved in Translation |
| 0.1 | 1.4 | REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.1 | 1.6 | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.1 | 1.2 | REACTOME_INSULIN_RECEPTOR_RECYCLING | Genes involved in Insulin receptor recycling |
| 0.1 | 0.4 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.1 | 1.4 | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.1 | 0.6 | REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.1 | 0.2 | REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.1 | 0.4 | REACTOME_KERATAN_SULFATE_DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.1 | 0.4 | REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.1 | 0.9 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.1 | 0.6 | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.1 | 2.0 | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 0.5 | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.0 | 0.3 | REACTOME_CS_DS_DEGRADATION | Genes involved in CS/DS degradation |
| 0.0 | 1.9 | REACTOME_NCAM1_INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.0 | 0.2 | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | Genes involved in Antigen processing-Cross presentation |
| 0.0 | 1.0 | REACTOME_PERK_REGULATED_GENE_EXPRESSION | Genes involved in PERK regulated gene expression |
| 0.0 | 2.5 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 0.2 | REACTOME_HYALURONAN_METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.0 | 0.0 | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
| 0.0 | 0.3 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.0 | 1.4 | REACTOME_GLUCOSE_METABOLISM | Genes involved in Glucose metabolism |
| 0.0 | 0.1 | REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.0 | 0.0 | REACTOME_MITOTIC_M_M_G1_PHASES | Genes involved in Mitotic M-M/G1 phases |
| 0.0 | 0.2 | REACTOME_COMMON_PATHWAY | Genes involved in Common Pathway |
| 0.0 | 0.5 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.0 | 0.2 | REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 0.0 | 0.2 | REACTOME_ADP_SIGNALLING_THROUGH_P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
| 0.0 | 0.2 | REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.0 | 0.3 | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.0 | 0.5 | REACTOME_MRNA_SPLICING_MINOR_PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.0 | 0.6 | REACTOME_RECYCLING_PATHWAY_OF_L1 | Genes involved in Recycling pathway of L1 |
| 0.0 | 0.2 | REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.0 | 0.4 | REACTOME_SIGNALING_BY_BMP | Genes involved in Signaling by BMP |
| 0.0 | 0.3 | REACTOME_MEIOTIC_RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.0 | 0.3 | REACTOME_DEADENYLATION_OF_MRNA | Genes involved in Deadenylation of mRNA |
| 0.0 | 0.0 | REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
| 0.0 | 0.4 | REACTOME_FANCONI_ANEMIA_PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.0 | 0.0 | REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.0 | 0.0 | REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.0 | 0.1 | REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.0 | 0.3 | REACTOME_DNA_REPAIR | Genes involved in DNA Repair |
|
|
|